{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:47:50Z","timestamp":1776725270597,"version":"3.51.2"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jdcr.2024.02.021","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T03:07:29Z","timestamp":1709608049000},"page":"23-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pityriasis lichenoides et varioliformis acuta in a patient treated with cevostamab"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6492-7273","authenticated-orcid":false,"given":"Jeremy","family":"Orloff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dev D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille M.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8922-6545","authenticated-orcid":false,"given":"Austin J.","family":"Piontkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4347-0710","authenticated-orcid":false,"given":"Nicholas","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jdcr.2024.02.021_bib1","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/cancers15061819","article-title":"Bispecific antibodies in multiple myeloma: opportunities to enhance efficacy and improve safety","volume":"15","author":"Swan","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.jdcr.2024.02.021_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/CCO.0000000000000983","article-title":"T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA","volume":"35","author":"van de Donk","year":"2023","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"10.1016\/j.jdcr.2024.02.021_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaad.2005.07.058","article-title":"Pityriasis lichenoides and its subtypes","volume":"55","author":"Bowers","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jdcr.2024.02.021_bib4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/hupa.2002.125381","article-title":"Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder","volume":"33","author":"Magro","year":"2002","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.jdcr.2024.02.021_bib5","doi-asserted-by":"crossref","DOI":"10.5070\/D32311037249","article-title":"Pityriasis lichenoides-like drug reaction: a clinical histopathologic study of 10 cases","volume":"23","author":"Magro","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jdcr.2024.02.021_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jdcr.2023.07.038","article-title":"Pityriasis lichenoides chronica in a patient on tafasitamab and lenalidomide therapy for\u00a0diffuse large B-cell lymphoma","volume":"40","author":"Roster","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"Supplement 1","key":"10.1016\/j.jdcr.2024.02.021_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood-2020-136980","article-title":"Early pharmacodynamic changes in T-cell activation, proliferation, and cytokine production confirm the mode of action of BFCR4350A, a FcRH5\/CD3 T-Cell-Engaging bispecific antibody, in patients with relapsed\/refractory multiple myeloma","volume":"136","author":"Nakamura","year":"2020","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.jdcr.2024.02.021_bib8","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1056\/NEJMoa2204591","article-title":"Talquetamab, a T-cell-redirecting GPRC5D bispecific antibody for multiple myeloma","volume":"387","author":"Chari","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdcr.2024.02.021_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/DDDT.S368954","article-title":"Tebentafusp in the treatment of metastatic uveal melanoma: patient selection and special considerations","volume":"17","author":"Montazeri","year":"2023","journal-title":"Drug Des Devel Ther"},{"issue":"8","key":"10.1016\/j.jdcr.2024.02.021_bib10","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1468-3083.2006.02129.x","article-title":"Pityriasis lichenoides chronica in a patient affected by multiple myeloma","volume":"21","author":"Menni","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262400081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262400081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T04:05:03Z","timestamp":1715832303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262400081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":10,"alternative-id":["S235251262400081X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.02.021","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pityriasis lichenoides et varioliformis acuta in a patient treated with cevostamab","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}